Opus Genetics Short Interest Surges in February

Shares of the ophthalmic biotech company see increased short selling activity.

Mar. 2, 2026 at 9:07pm

Got story updates? Submit your updates here. ›

Opus Genetics, Inc. (NASDAQ:IRD), a clinical-stage ophthalmic biopharmaceutical company, saw a significant increase in short interest in February. As of February 13th, there was short interest totaling 942,054 shares, an increase of 41.8% from the January 29th total of 664,201 shares. The short-interest ratio is currently 0.7 days, indicating that approximately 1.5% of the company's stock is sold short.

Why it matters

The rise in short interest suggests that some investors are betting against Opus Genetics' stock performance, potentially due to concerns about the company's financial outlook or the progress of its ophthalmic drug development pipeline. This could signal increased volatility in the stock price as short sellers look to cover their positions.

The details

Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company's stock has seen significant price fluctuations in recent months, with the share price reaching a 52-week high of $4.17 on Friday, March 1st.

  • As of February 13th, 2026, there was short interest totaling 942,054 shares in Opus Genetics.
  • This represents an increase of 41.8% from the January 29th, 2026 total of 664,201 shares.

The players

Opus Genetics, Inc.

A clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders.

Cam Gallagher

A director at Opus Genetics who purchased 83,000 shares of the company's stock in a transaction on December 29th, 2025.

Fighting Blindness Foundation

A director at Opus Genetics who sold 4,000,000 shares of the company's stock in a transaction on December 9th, 2025.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.